| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2022 | A Agilent Technologies, Inc. | Ancher-Jensen Henrik49 | Sr Vice President | Sell | 29,500 | $155.78 | $4,595,510.00 | -29.4% | -10.6% | -10.9% | |
| Dec 14, 2022 | TMO Thermo Fisher Scientific Inc. | Pettiti Gianluca63 | Executive Vice President | Sell | 6,975 | $574.62 | $4,007,999.00 | -18.4% | -2.0% | -8.1% | |
| Dec 13, 2022 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 1,667 | $30.71 | $51,196.71 | -1.6% | -23.9% | -7.8% | |
| Dec 13, 2022 | A Agilent Technologies, Inc. | Grau Dominique70 | Senior Vice President | Sell | 4,000 | $159.20 | $636,800.00 | -4.2% | -13.3% | -15.2% | |
| Dec 13, 2022 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 67,402 | $1.58 | $106,528.86 | +0.3% | -3.5% | -7.6% | |
| Dec 13, 2022 | A Agilent Technologies, Inc. | McDonnell Padraig71 | Sr. Vice President | Sell | 672 | $160.00 | $107,520.00 | -4.1% | -13.3% | -15.2% | |
| Dec 12, 2022 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 100,000 | $1.48 | $148,380.00 | +0.5% | +8.6% | +3.3% | |
| Dec 9, 2022 | NDRA Endra Life Sciences Inc. | Thornton Michael Milos45 | Chief Technology Officer | Buy | 1,500 | $3.40 | $5,100.00 | +8.5% | +17.9% | -55.4% | |
| Dec 9, 2022 | NOTV Inotiv, Inc. | Pitchford William D | Chief Human Resources Officer | Sell | 2,123 | $5.82 | $12,365.63 | -2.8% | -5.5% | -40.5% | |
| Dec 8, 2022 | XGN Exagen Inc. | Aballi John64 | President And CEO | Buy | 90,000 | $2.68 | $241,200.00 | +25.7% | -5.1% | -38.1% | |
| Dec 7, 2022 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,645 | $38.31 | $101,330.21 | -3.2% | +48.9% | +50.7% | |
| Dec 6, 2022 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 1,023 | $27.03 | $27,651.69 | -1.5% | -12.9% | -5.7% | |
| Dec 6, 2022 | A Agilent Technologies, Inc. | Koh Boon Hwee | Director | Sell | 13,000 | $152.21 | $1,978,692.30 | -18.4% | -5.4% | -14.8% | |
| Dec 6, 2022 | XWEL Xwell, Inc. | Milford Scott R62 | Chief Executive Officer | Buy | 28,750 | $0.54 | $15,419.85 | +93.9% | -23.7% | -82.9% | |
| Dec 5, 2022 | WST West Pharmaceutical Services Inc | Green Eric Mark57 | President &CEO | Sell | 44,000 | $238.99 | $10,515,518.36 | -5.3% | +35.2% | +43.8% | |
| Dec 5, 2022 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,958 | $24.79 | $222,068.82 | -1.4% | -0.5% | -18.8% | |
| Dec 2, 2022 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 440 | $2.60 | $1,144.00 | -0.3% | -8.7% | -48.8% | |
| Dec 2, 2022 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 653 | $35.33 | $23,069.71 | -0.3% | -7.7% | -24.1% | |
| Dec 2, 2022 | CRL Charles River Laboratories International, Inc. | Wallman Richard F81 | Director | Buy | 1,500 | $218.90 | $328,350.00 | +8.1% | +1.6% | -9.4% | |
| Dec 2, 2022 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 4,360 | $2.60 | $11,336.00 | -2.0% | -8.7% | -48.8% | |
| Dec 2, 2022 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 8,465 | $0.40 | $3,360.61 | -35.8% | +8.9% | -86.9% | |
| Dec 2, 2022 | CRL Charles River Laboratories International, Inc. | Barbo William D66 | Corporate Executive VP &CCO | Sell | 3,205 | $219.91 | $704,814.08 | -13.4% | +1.6% | -9.4% | |
| Dec 1, 2022 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 6,409 | $224.25 | $1,437,204.80 | -8.7% | -1.5% | -10.8% | |
| Dec 1, 2022 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Executive Chairwoman | Sell | 80,000 | $28.26 | $2,260,748.34 | -31.3% | -17.8% | -7.9% | |
| Dec 1, 2022 | NOTV Inotiv, Inc. | Neff R Matthew92 | Director | Sell | 1,000 | $6.12 | $6,120.00 | -1.6% | +24.0% | -48.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.